Agency Information Collection Activities; Submission for OMB Review; Comment Request; Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs (OWCP-26), 48193-48194 [2024-12277]

Download as PDF 48193 Federal Register / Vol. 89, No. 109 / Wednesday, June 5, 2024 / Notices Abstract: The Attorney General is required by statute to ‘‘assure that any property transferred to a State or local law enforcement agency . . . will serve to encourage further cooperation between the recipient State or local agency and Federal law enforcement agencies.’’ 21 U.S.C. 881(e)(3). MLARS ensures such cooperation by requiring that all such ‘‘equitably shared’’ funds be used only for law enforcement purposes and not be distributed to other governmental agencies by the recipient law enforcement agencies. By requiring that law enforcement agencies that participate in the Equitable Sharing Program (Program) file an Equitable Sharing Agreement and Certification (ESAC), MLARS can readily ensure compliance with its statutory obligations. The ESAC requires information regarding the receipt and expenditure of Program funds from the participating agency. Accordingly, it seeks information that is exclusively in the hands of the participating agency and governing jurisdiction. This collection request is classified as a revision due to updated requirements incorporated in a revised version of the Guide to Equitable Sharing for State, Local, and Tribal Law Enforcement Agencies, in addition to format changes and deleting and relabeling some fields. Overview of This Information Collection 1. Type of Information Collection: Revision of a previously approved collection. 2. The Title of the Form/Collection: Equitable Sharing Agreement and Certification. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: There is not an agency form number. The collection instrument is the Equitable Sharing Agreement and Certification. The applicable component within the Department of Justice is the Money Laundering and Asset Recovery Section (‘‘MLARS’’), in the Criminal Division. 4. Affected public who will be asked or required to respond, as well as the obligation to respond: Affected Public State, local and tribal law enforcement agencies and governing jurisdictions participating in the Program. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An estimated 6,000 respondents will respond to this collection. The time per response is approximately .5 hours. 6. An estimate of the total annual burden (in hours) associated with the collection: The total annual burden hours for this collection is approximately 3,000 hours. 7. An estimate of the total annual cost burden associated with the collection, if applicable: TOTAL BURDEN HOURS Number of respondents Activity Total annual responses Time per response (hours) Total annual burden (hours) Equitable Sharing Agreement and Certification .................. 6,000 1/annually ...... 6,000 .5 3,000 Unduplicated Totals ...................................................... 6,000 ........................ 6,000 ........................ 3,000 If additional information is required contact: Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 4W–218, Washington, DC. Dated: May 30, 2024. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2024–12250 Filed 6–4–24; 8:45 am] BILLING CODE 4410–14–P DEPARTMENT OF LABOR khammond on DSKJM1Z7X2PROD with NOTICES Frequency Agency Information Collection Activities; Submission for OMB Review; Comment Request; Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs (OWCP–26) Notice of availability; request for comments. ACTION: The Department of Labor (DOL) is submitting this Office of Workers’ Compensation Programs SUMMARY: VerDate Sep<11>2014 16:50 Jun 04, 2024 Jkt 262001 (OWCP)-sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that the agency receives on or before July 5, 2024. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Michelle Neary by telephone at 202– 693–6312, or by email at DOL_PRA_ PUBLIC@dol.gov. SUPPLEMENTARY INFORMATION: OWCP will require the claimant’s treating physician to complete a Form OWCP–26 online before payment will be made for a compounded drug. The physician will be required to specify the ingredients in the compounded drug, indicate whether PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 the compounded drug and each of its ingredients are medically necessary, and explain why the claimant cannot use an FDA-approved drug instead of the compounded drug being prescribed. The form will permit the OWCP to more easily track the volume, type, and characteristics of compounded drugs prescribed for claimants. It will allow additional oversight of the pharmacy benefit—improving patient safety, decreasing cost for stakeholders, and decreasing the risk for fraud, waste, and abuse. Completed forms will be reviewed by a clinical pharmacist or physician before being reviewed for decision by the individual program staff. For additional substantive information about this ICR, see the related notice published in the Federal Register on March 26, 2024 (89 FR 21015). Comments are invited on: (1) whether the collection of information is necessary for the proper performance of the functions of the Department, including whether the information will have practical utility; (2) if the information will be processed and used in a timely manner; (3) the accuracy of the agency’s estimates of the burden and E:\FR\FM\05JNN1.SGM 05JNN1 48194 Federal Register / Vol. 89, No. 109 / Wednesday, June 5, 2024 / Notices cost of the collection of information, including the validity of the methodology and assumptions used; (4) ways to enhance the quality, utility and clarity of the information collection; and (5) ways to minimize the burden of the collection of information on those who are to respond, including the use of automated collection techniques or other forms of information technology. This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless the OMB approves it and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid OMB Control Number. See 5 CFR 1320.5(a) and 1320.6. DOL seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOL notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. Agency: DOL–OWCP. Title of Collection: Authorization Request Form and Certification/Letter of Medical Necessity for Compounded Drugs (OWCP–26). OMB Control Number: 1240–0NEW. Affected Public: Private Sector— Businesses or other for-profits. Total Estimated Number of Respondents: 78. Total Estimated Number of Responses: 490. Total Estimated Annual Time Burden: 245 hours. Total Estimated Annual Other Costs Burden: $0. (Authority: 44 U.S.C. 3507(a)(1)(D)) Michelle Neary, Senior Paperwork Reduction Act Analyst. [FR Doc. 2024–12277 Filed 6–4–24; 8:45 am] khammond on DSKJM1Z7X2PROD with NOTICES BILLING CODE 4510–CR–P VerDate Sep<11>2014 16:50 Jun 04, 2024 Jkt 262001 DEPARTMENT OF LABOR Agency Information Collection Activities; Submission for OMB Review; Comment Request; Electric Power Generation, Transmission, and Distribution Standard for Construction and General Industry and Electrical Protective Equipment for Construction and General Industry Notice of availability; request for comments. ACTION: The Department of Labor (DOL) is submitting this Occupational Safety & Health Administration (OSHA)sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that the agency receives on or before July 5, 2024. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Nicole Bouchet by telephone at 202– 693–0213, or by email at DOL_PRA_ PUBLIC@dol.gov. SUPPLEMENTARY INFORMATION: The information collection requirements specified in the Electrical Power Transmission and Distribution Standard for Construction and the Electric Power Transmission and Distribution Standard provide employees with safe work practices that guard against exposure to electrical shock hazards in workplace. For additional substantive information about this ICR, see the related notice published in the Federal Register on March 25, 2024 (89 FR 20703). Comments are invited on: (1) whether the collection of information is necessary for the proper performance of the functions of the Department, including whether the information will have practical utility; (2) the accuracy of the agency’s estimates of the burden and cost of the collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility and clarity of the information collection; and (4) ways to minimize the burden of the collection of information on those who SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 are to respond, including the use of automated collection techniques or other forms of information technology. This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless the OMB approves it and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid OMB Control Number. See 5 CFR 1320.5(a) and 1320.6. DOL seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOL notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. Agency: DOL–OSHA. Title of Collection: Electric Power Generation, Transmission, and Distribution Standard for Construction and General Industry and Electrical Protective Equipment for Construction and General Industry. OMB Control Number: 1218–0253. Affected Public: Private Sector— Businesses or other for-profits. Total Estimated Number of Respondents: 21,396. Total Estimated Number of Responses: 2,067,172. Total Estimated Annual Time Burden: 394,614 hours. Total Estimated Annual Other Costs Burden: $0. (Authority: 44 U.S.C. 3507(a)(1)(D)) Nicole Bouchet, Certifying Official. [FR Doc. 2024–12276 Filed 6–4–24; 8:45 am] BILLING CODE 4510–26–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: 24–035] Name of Information Collection: NASA/ KSC Business Opportunities Expo National Aeronautics and Space Administration (NASA). ACTION: Notice of information collection. AGENCY: The National Aeronautics and Space Administration, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal SUMMARY: E:\FR\FM\05JNN1.SGM 05JNN1

Agencies

[Federal Register Volume 89, Number 109 (Wednesday, June 5, 2024)]
[Notices]
[Pages 48193-48194]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12277]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF LABOR


Agency Information Collection Activities; Submission for OMB 
Review; Comment Request; Authorization Request Form and Certification/
Letter of Medical Necessity for Compounded Drugs (OWCP-26)

ACTION: Notice of availability; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Department of Labor (DOL) is submitting this Office of 
Workers' Compensation Programs (OWCP)-sponsored information collection 
request (ICR) to the Office of Management and Budget (OMB) for review 
and approval in accordance with the Paperwork Reduction Act of 1995 
(PRA). Public comments on the ICR are invited.

DATES: The OMB will consider all written comments that the agency 
receives on or before July 5, 2024.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Michelle Neary by telephone at 202-
693-6312, or by email at [email protected].

SUPPLEMENTARY INFORMATION: OWCP will require the claimant's treating 
physician to complete a Form OWCP-26 online before payment will be made 
for a compounded drug. The physician will be required to specify the 
ingredients in the compounded drug, indicate whether the compounded 
drug and each of its ingredients are medically necessary, and explain 
why the claimant cannot use an FDA-approved drug instead of the 
compounded drug being prescribed. The form will permit the OWCP to more 
easily track the volume, type, and characteristics of compounded drugs 
prescribed for claimants. It will allow additional oversight of the 
pharmacy benefit--improving patient safety, decreasing cost for 
stakeholders, and decreasing the risk for fraud, waste, and abuse. 
Completed forms will be reviewed by a clinical pharmacist or physician 
before being reviewed for decision by the individual program staff. For 
additional substantive information about this ICR, see the related 
notice published in the Federal Register on March 26, 2024 (89 FR 
21015).
    Comments are invited on: (1) whether the collection of information 
is necessary for the proper performance of the functions of the 
Department, including whether the information will have practical 
utility; (2) if the information will be processed and used in a timely 
manner; (3) the accuracy of the agency's estimates of the burden and

[[Page 48194]]

cost of the collection of information, including the validity of the 
methodology and assumptions used; (4) ways to enhance the quality, 
utility and clarity of the information collection; and (5) ways to 
minimize the burden of the collection of information on those who are 
to respond, including the use of automated collection techniques or 
other forms of information technology.
    This information collection is subject to the PRA. A Federal agency 
generally cannot conduct or sponsor a collection of information, and 
the public is generally not required to respond to an information 
collection, unless the OMB approves it and displays a currently valid 
OMB Control Number. In addition, notwithstanding any other provisions 
of law, no person shall generally be subject to penalty for failing to 
comply with a collection of information that does not display a valid 
OMB Control Number. See 5 CFR 1320.5(a) and 1320.6.
    DOL seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOL notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.
    Agency: DOL-OWCP.
    Title of Collection: Authorization Request Form and Certification/
Letter of Medical Necessity for Compounded Drugs (OWCP-26).
    OMB Control Number: 1240-0NEW.
    Affected Public: Private Sector--Businesses or other for-profits.
    Total Estimated Number of Respondents: 78.
    Total Estimated Number of Responses: 490.
    Total Estimated Annual Time Burden: 245 hours.
    Total Estimated Annual Other Costs Burden: $0.

(Authority: 44 U.S.C. 3507(a)(1)(D))

Michelle Neary,
Senior Paperwork Reduction Act Analyst.
[FR Doc. 2024-12277 Filed 6-4-24; 8:45 am]
BILLING CODE 4510-CR-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.